- Concurrent cancer and mental health disorders elevate risk of treatment nonadherence, worsening prognosis and increasing morbidity and mortality.
- Treatment nonadherence substantially impairs outcomes due to inadequate recognition and management of psychological comorbidities.
- Targeted education and support can enhance oncology nurses' confidence and motivation to identify and address adherence barriers in patients with MHDs.
Clin J Oncol Nurs. 2026 May 18;30(3):193-198. doi: 10.1188/26.CJON.193-198.
ABSTRACT
Patients with concurrent cancer and mental health disorders (MHDs) are at risk for treatment nonadherence (TN), increasing their risk of poor prognosis. TN significantly affects patient outcomes because of inadequate manageme.
PMID:42227792 | DOI:10.1188/26.CJON.193-198
Share Evidence Blueprint
Save to Google Notes

Search Google Scholar
⭐ My Revision List

